$吉利德科学(GIL_老虎社区_美港股上老虎 - 老虎社区

$吉利德科学(GILD)$哪位朋友知道武汉临床试验进展情况？分享一下[开心]
期待前线阶段性效果速递。
相信一定有惊喜。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

君子有道
2020-02-07
君子有道
针对药物瑞德西韦的随机双盲对照试验，湖北省医疗救治组专家、华中科技大学同济医院呼吸与危重症医学科主任赵建平7日透露，目前在分组上对重症病人有相应倾斜，“以前分组是1：1，1份治疗用药，1份对照组。这次是2：1，若参加研究有66%的机会用上这个药。” 赵建平表示，其他患者不会因为没有用上瑞德西韦延误病情。
君子有道
2020-02-07
君子有道
是呀！双盲就有一部分病人耽误真正用药时间

发表看法

2

6

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":914355503,"tweetId":"914355503","gmtCreate":1581066404902,"gmtModify":1704343412457,"author":{"id":3443440006352800,"idStr":"3443440006352800","authorId":3443440006352800,"authorIdStr":"3443440006352800","name":"君子有道","avatar":"https://static.tigerbbs.com/4dffc837e31aec1564b7dd0e8167a2c0","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":128,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body> <a href=\"https://laohu8.com/S/GILD\">$吉利德科学(GILD)$</a>哪位朋友知道武汉临床试验进展情况？分享一下[开心]<br>期待前线阶段性效果速递。<br>相信一定有惊喜。<br><br></body></html>","htmlText":"<html><head></head><body> <a href=\"https://laohu8.com/S/GILD\">$吉利德科学(GILD)$</a>哪位朋友知道武汉临床试验进展情况？分享一下[开心]<br>期待前线阶段性效果速递。<br>相信一定有惊喜。<br><br></body></html>","text":"$吉利德科学(GILD)$哪位朋友知道武汉临床试验进展情况？分享一下[开心] 期待前线阶段性效果速递。 相信一定有惊喜。","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/914355503","repostId":0,"isVote":1,"tweetType":1,"viewCount":2826,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["GILD"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":103,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":2123606,"commentId":"2123606","gmtCreate":1581087760536,"gmtModify":1581087760536,"authorId":3443440006352800,"author":{"id":3443440006352800,"idStr":"3443440006352800","authorId":3443440006352800,"name":"君子有道","avatar":"https://static.tigerbbs.com/4dffc837e31aec1564b7dd0e8167a2c0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":914355503,"objectIdStr":"914355503","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"针对药物瑞德西韦的随机双盲对照试验，湖北省医疗救治组专家、华中科技大学同济医院呼吸与危重症医学科主任赵建平7日透露，目前在分组上对重症病人有相应倾斜，“以前分组是1：1，1份治疗用药，1份对照组。这次是2：1，若参加研究有66%的机会用上这个药。” 赵建平表示，其他患者不会因为没有用上瑞德西韦延误病情。 ","text":"针对药物瑞德西韦的随机双盲对照试验，湖北省医疗救治组专家、华中科技大学同济医院呼吸与危重症医学科主任赵建平7日透露，目前在分组上对重症病人有相应倾斜，“以前分组是1：1，1份治疗用药，1份对照组。这次是2：1，若参加研究有66%的机会用上这个药。” 赵建平表示，其他患者不会因为没有用上瑞德西韦延误病情。 ","html":"针对药物瑞德西韦的随机双盲对照试验，湖北省医疗救治组专家、华中科技大学同济医院呼吸与危重症医学科主任赵建平7日透露，目前在分组上对重症病人有相应倾斜，“以前分组是1：1，1份治疗用药，1份对照组。这次是2：1，若参加研究有66%的机会用上这个药。” 赵建平表示，其他患者不会因为没有用上瑞德西韦延误病情。 ","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":2123619,"commentId":"2123619","gmtCreate":1581087881746,"gmtModify":1581087881746,"authorId":3443440006352800,"author":{"id":3443440006352800,"idStr":"3443440006352800","authorId":3443440006352800,"name":"君子有道","avatar":"https://static.tigerbbs.com/4dffc837e31aec1564b7dd0e8167a2c0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":914355503,"objectIdStr":"914355503","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"是呀！双盲就有一部分病人耽误真正用药时间  ","text":"是呀！双盲就有一部分病人耽误真正用药时间  ","html":"是呀！双盲就有一部分病人耽误真正用药时间  ","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/914355503"}